In 1917, Florence Sabin, the first female member of the US National Academy of Sciences, discovered hemangioblasts, the common precursor cells for blood cells and blood vessel endothelia. Her discovery faced a great deal ...
Cell & Microbiology
Jan 20, 2016
0
9
Pluripotent stem cells derived from different cell types are equally susceptible to reprogramming, indicates a recent study.
Cell & Microbiology
Jan 14, 2016
0
4
Two phases of the cell cycle of human embryonic stem cells have been shown, for the first time, to actively employ pathways that maintain pluripotency—the potential to develop into almost any type of cell in the body.
Cell & Microbiology
Nov 4, 2015
0
13
"We can rebuild him. We have the technology." - The Six Million Dollar Man, 1973
Engineering
Aug 31, 2015
0
113
Singapore scientists from A*STAR's Genome Institute of Singapore (GIS) have, for the first time, found further evidence of how the differentiation of pluripotent cells is tied to and controlled by the cell cycle clock. This ...
Cell & Microbiology
Aug 6, 2015
0
91
Since 2006, research has succeeded in generating, from specialised adult cells, induced pluripotent cells (iPS cells), with huge potential applications, particularly for regenerative medicine. However, the process has still ...
Cell & Microbiology
Jul 8, 2015
0
15
Tissue Regeneration Materials Unit at MANA, NIMS successfully developed gold nanoparticles that have functional surfaces and act on osteogenic differentiation of stem cells.
Bio & Medicine
May 21, 2015
0
31
A study using Super-resolution microscopy reveals that our genome is not regularly packaged and links these packaging differences to stem cell state. A multidisciplinary approach allowed scientists to view and even count, ...
Cell & Microbiology
Mar 12, 2015
0
25
A protein that helps embryonic stem cells (ESCs) retain their identity also promotes DNA repair, according to a study in The Journal of Cell Biology. The findings raise the possibility that the protein, Sall4, performs a ...
Cell & Microbiology
Mar 2, 2015
0
14
Rutgers University Chemistry Associate Professor Ki-Bum Lee has developed patent-pending technology that may overcome one of the critical barriers to harnessing the full therapeutic potential of stem cells.
Biochemistry
Nov 13, 2014
0
0
